Literature DB >> 23280611

First structural evidence of sequestration of mRNA cap structures by type 1 ribosome inactivating protein from Momordica balsamina.

Gajraj Singh Kushwaha1, Shavait Yamini, Mukesh Kumar, Mau Sinha, Punit Kaur, Sujata Sharma, Tej P Singh.   

Abstract

This is the first structural evidence of recognition of mRNA cap structures by a ribosome inactivating protein. It is well known that a unique cap structure is formed at the 5' end of mRNA for carrying out various processes including mRNA maturation, translation initiation, and RNA turnover. The binding studies and crystal structure determinations of type 1 ribosome inactivating protein (RIP-1) from Momordica balsamina (MbRIP-1) were carried out with mRNA cap structures including (i) N7-methyl guanine (m7G), (ii) N7-methyl guanosine diphosphate (m7GDP), and (iii) N7-methyl guanosine triphosphate (m7GTP). These compounds showed affinities to MbRIP-1 at nanomolar concentrations. The structure determinations of the complexes of MbRIP-1 with m7G, m7GDP, and m7GTP at 2.65, 1.77, and 1.75 Å resolutions revealed that all the three compounds bound to MbRIP-1 in the substrate binding site at the positions which are slightly shifted towards Glu85 as compared to those of rRNA substrates. In this position, Glu85 forms several hydrogen bonds with guanine moiety while N-7 methyl group forms van der Waals contacts. However, the guanine rings are poorly stacked in these complexes. Thus, the mode of binding by MbRIP-1 to mRNA cap structures is different which results in the inhibition of depurination. Since some viruses are known to exploit the capping property of the host, this action of MbRIP-1 may have implications for the antiviral activity of this protein in vivo. The understanding of the mode of binding of MbRIP-1 to cap structures may also assist in the design of anti-viral agents.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23280611     DOI: 10.1002/prot.24248

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  5 in total

Review 1.  Ribosome-inactivating and related proteins.

Authors:  Joachim Schrot; Alexander Weng; Matthias F Melzig
Journal:  Toxins (Basel)       Date:  2015-05-08       Impact factor: 4.546

2.  Binding and structural studies of the complexes of type 1 ribosome inactivating protein from Momordica balsamina with cytosine, cytidine, and cytidine diphosphate.

Authors:  Shavait Yamini; S N Pandey; Punit Kaur; Sujata Sharma; T P Singh
Journal:  Biochem Biophys Rep       Date:  2015-09-11

Review 3.  Antiviral Activity of Ribosome-Inactivating Proteins.

Authors:  Lucía Citores; Rosario Iglesias; José M Ferreras
Journal:  Toxins (Basel)       Date:  2021-01-22       Impact factor: 4.546

Review 4.  Detect, correct, retract: How to manage incorrect structural models.

Authors:  Alexander Wlodawer; Zbigniew Dauter; Przemyslaw J Porebski; Wladek Minor; Robyn Stanfield; Mariusz Jaskolski; Edwin Pozharski; Christian X Weichenberger; Bernhard Rupp
Journal:  FEBS J       Date:  2017-11-27       Impact factor: 5.542

5.  The mode of inhibitor binding to peptidyl-tRNA hydrolase: binding studies and structure determination of unbound and bound peptidyl-tRNA hydrolase from Acinetobacter baumannii.

Authors:  Sanket Kaushik; Nagendra Singh; Shavait Yamini; Avinash Singh; Mau Sinha; Ashish Arora; Punit Kaur; Sujata Sharma; Tej P Singh
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.